arrow
W

Wei-Wen Su

hopital universitaire beaujon - aphp
H指数:28
被引数:4,035

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Outcomes of nucleos(t)ide analogue discontinuation following finite xalnesiran-based therapies in chronic hepatitis B

慢性乙型肝炎患者接受有限疗程的昔奈西仑治疗后核苷(类)类似物停药的临床结局

2026-09-010
PRE
Changhua Integrated Program to Stop HCV Infection (CHIPS–C): A county-wide model for integrated HCV elimination in Taiwan

彰化整合计划以阻止HCV感染(CHIPS–C):台湾县级整合HCV消除的模型

2025-10-220
OAAI
Switching to tenofovir alafenamide in virally-suppressed chronic hepatitis B patients with renal/hepatic impairment: Phase 2 study sub-analysis from Taiwan

将病毒学抑制的慢性乙型肝炎合并肾功能/肝功能不全患者转换为替诺福韦艾拉酚胺:台湾地区II期研究子分析

2025-07-300
OA
Impact of Hepatitis C Virus Clearance on Cardiovascular Risk: A Real-World Experience From the Nationwide Taiwan Hepatitis C Virus Registry

丙型肝炎病毒清除对心血管风险的影响: 来自全国台湾丙型肝炎病毒登记处的真实经验

2025-05-240
OAAI
Xalnesiran with or without an Immunomodulator in Chronic Hepatitis B
2024-12-050
PRE
Metformin and statins reduce hepatocellular carcinoma risk in chronic hepatitis C patients with failed antiviral therapy
2024-07-016
OAAI
An algorithm for simplified hepatitis C virus treatment with non-specialist care based on nation-wide data from Taiwan
2024-01-213
OAAI
Using the Diabetes Care System for a County-Wide Hepatitis C Elimination: An Integrated Community-Based Shared Care Model in Taiwan

使用糖尿病护理系统在全县范围内消除丙型肝炎: 台湾基于社区的综合共享护理模式

2023-11-170
OAAI
Effectiveness and safety of 8-week glecaprevir/pibrentasvir in HCV treatment-naive patients with compensated cirrhosis: real-world experience from Taiwan nationwide HCV registry
2023-03-278
OAAI
Metformin reduces hepatocellular carcinoma incidence after successful antiviral therapy in patients with diabetes and chronic hepatitis C in Taiwan
2023-02-0139
PRE
Sofosbuvir/velpatasvir/voxilaprevir for patients with chronic hepatitis C virus infection previously treated with NS5A direct-acting antivirals: a real-world multicenter cohort in Taiwan

Sofosbuvir/velpatasvir/voxilaprevir用于先前接受NS5A直接作用抗病毒药物治疗的慢性丙型肝炎病毒感染患者: 台湾真实世界的多中心队列

2023-01-2614
OA
Impact of Sofosbuvir-Based Direct-Acting Antivirals on Renal Function in Chronic Hepatitis C Patients With Impaired Renal Function: A Large Cohort Study From the Nationwide HCV Registry Program (TACR)
2022-05-0123
PRE
Factors Associated with Significant Platelet Count Improvement in Thrombocytopenic Chronic Hepatitis C Patients Receiving Direct-Acting Antivirals
2022-02-074
OAAI